SCHEMBL4593608

SCHEMBL4593608

Nc1ccc(-c2nc3ccccc3s2)cc1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.69
KDM4E B2RXH2 10/20 0.64
NPC1 O15118 10/20 0.64
MAPT P10636 9/20 0.64
ALDH1A1 P00352 6/20 0.64
SMN1; SMN2 Q16637 6/20 0.64
KMT2A Q03164 6/20 0.64
MEN1 O00255 5/20 0.64
HSD17B10 Q99714 4/20 0.64
TP53 P04637 3/20 0.64
HPGD P15428 3/20 0.64
NPSR1 Q6W5P4 2/20 0.64
HCRTR1 O43613 1/20 0.64
MAPK1 P28482 1/20 0.64
BLM P54132 1/20 0.64
RAB9A P51151 10/20 0.62
GAA P10253 4/20 0.62
GLA P06280 3/20 0.62
LMNA P02545 3/20 0.62
MMP9 P14780 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11193289 0.88 RAB9A (0.66) APPKDM4ENPC1MAPTALDH1A1
Hydrochloric Acid SCHEMBL11197196 0.87 RAB9A (0.64) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL7836371 0.86 APP (0.75) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL12470903 0.86 KDM4E (0.69) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL30466258 0.86 KDM4E (0.69) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL8397690 0.84 APP (0.73) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL30714873 0.84 KDM4E (0.74) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL9293186 0.84 KDM4E (0.74) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL1978135 0.82 APP (0.69) APPKDM4ENPC1MAPTALDH1A1
SCHEMBL12227064 0.82 APP (0.69) APPKDM4ENPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910349-A1 2-ARYLBENZOTHIAZOLES AND USES THEREOF 4SC AG (DE) 2008-04-16 EP disclosed
WO-2007009524-A1 2-ARYLBENZOTHIAZOLES AND USES THEREOF 4SC AG (DE) 2007-01-25 WO disclosed
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof 4SC AG (DE) 2007-01-25 US disclosed
EP-1746096-A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer 4SC AG (DE) 2007-01-24 EP disclosed
EP-1746096-A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer 4SC AG (DE) 2007-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021446-A1 2-arylbenzothiazole analogues and uses thereof NR2E1, NR2E3, NR0B2 APP 2819/4885KDM4E 2243/4885NPC1 4075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.